Newborn Screening Market (2018-2025) Expanding In Disorder Screening Industry And Forecasting Natus Medical, Masimo, Medtronic, Intelligent Hearing Systems and More

The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Major factors contributing to the growth of the market includes factors such as rising prevalence of new born screening, growth in neonatal diseases, increased government funding and technological advancements.

Newborn Screening Market was valued at USD 1,008.64 million in 2017, and is expected to reach USD 2,258.12 million by 2025, growing at a CAGR of 10.7% in the forecast period 2018 to 2025. High cost of automated devices and stringent regulatory policies are restricting the growth of the market.

Get Free Sample PDF of This Research Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-newborn-screening-market

The key market players for global newborn screening market are listed below:

PerkinElmer Inc.
Trivitron Healthcare
Interacoustics A/S
Bio-Rad Laboratories, Inc.
Natus Medical Incorporated
Masimo
Medtronic
Intelligent Hearing Systems
Interacoustics A/S
Otodynamics Ltd
Vivosonic Inc.
ZenTech S.A.
AB Sciex
Welch Allyn
Baebies, Inc.
 

The Global Newborn Screening Market is segmented on the basis of test types into dried blood spot (DBS) test, critical congenital heart diseases (CCHD) test and hearing screen test. In 2018, dried blood spot is anticipated to lead the market with 44.0% shares and will grow at USD 974.54 million by 2025. It is exceeding at the CAGR of 10.4% in the forecast period.

The global newborn screening market is divided based on product type into instruments and reagents & assay kits. In 2018, the instruments market is estimated to dominate market with 67.7% shares and will collect around 1,553.89 million by 2025, rising at the maximum CAGR of 11.0%. The instruments are further sub- segmented into newborn disorder screening, newborn hearing screening, and pulse oximeter.

On the basis of technologies, the global newborn screening market is segmented into tandem mass spectrometry, hearing screen, pulse oximetry screening, immunoassays and enzymatic assays, electrophoresis and DNA-based assays. In 2018, tandem mass spectrometry market is likely to dominate market with 26.9% shares and is estimated to reach 647.98 million by 2025. It is growing at the highest CAGR of 11.7% in the forecast period.

The global newborn screening market is categorized based on disease type into phenylketonuria, cystic fibrosis, sickle cell disease, newborn hearing loss, critical congenital heart diseases, maple syrup urine disease and others. In 2018, critical congenital heart diseases market will dominate with 64.8% shares and will consume around 1,492.98 million by 2025. It is growing at the highest CAGR of 11.0% in the assessment period.

The global newborn screening market is divided on the basis of end user into hospitals, pediatric clinics, and clinics. In 2018, hospitals market is expected to dominate market with 71.3% shares and is estimated to reach 1,633.21 million by 2025, growing at the highest CAGR of 10.9%.

North America Industry Segmentation

North America newborn screening market is estimated to reach USD 1,018.49 million by 2025 from USD 458.93 million in 2017, at a CAGR of 10.6% in the forecast period 2018 to 2025.

Test Type: Dried blood spot is anticipated to lead the market with 43.0% shares and will cross USD 430.34 million by 2025. It is exceeding at the CAGR of 10.3% in the forecast period.

Product Type: Rising at the maximum CAGR of 10.9%. The instruments segment is further sub- segmented into newborn disorder screening, newborn hearing screening, and pulse oximeter.

Technology: Tandem mass spectrometry market is likely to dominate market with 26.5% shares and is estimated to reach 295.44 million by 2025. It is growing at the highest CAGR of 12.0% in the forecast period.

Disease Type: Critical congenital heart diseases market will dominate with 64.4% shares and will consume around 670.15 million by 2025. It is growing at the highest CAGR of 10.9% in the assessment period.

End-user: Hospitals market is expected to dominate market with 71.0% shares and is estimated to reach 734.96 million by 2025, growing at the highest CAGR of 10.8%.

Europe Industry Segmentation

Europe newborn screening market is projected to cross USD 564.45 million by 2025 from USD 248.13 million in 2017, at a CAGR of 10.9% in the forecast period 2018 to 2025.

Test Type: Dried blood spot is anticipated to lead the market with 44.0% shares and will grow at USD 243.68 million by 2025. It is exceeding at the CAGR of 10.6% in the forecast period.

Product Type: Instruments market is estimated to dominate market with 67.8% shares and will collect around 388.35 million by 2025, rising at the maximum CAGR of 11.2%. The instruments are further sub- segmented into newborn disorder screening, newborn hearing screening, and pulse oximeter.

Technology: Tandem mass spectrometry market is likely to dominate market with 26.9% shares and is estimated to reach 158.66 million by 2025. It is growing at the highest CAGR of 11.6% in the forecast period.

Disease Type: Critical congenital heart diseases market will dominate with 64.8% shares and will consume around 373.20 million by 2025. It is growing at the highest CAGR of 11.2% in the assessment period.

End-user: Hospitals market is expected to dominate market with 71.1% shares and is estimated to reach 407.47 million by 2025, growing at the highest CAGR of 11.2%.

Speak to Research Analyst for Regional Customization or Other Query: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-newborn-screening-market

Asia-Pacific Industry Segmentation

Asia Pacific newborn screening market is expected to reach USD 432.41 million by 2025 from USD 185.59 million in 2017, at a CAGR of 11.3% in the forecast period 2018 to 2025.

Test Type: Dried blood spot is anticipated to lead the market with 44.3% shares and will grow at USD 187.47 million by 2025. It is exceeding at the CAGR of 10.9% in the forecast period.

Product Type: Instruments market is estimated to dominate market with 68.0% shares and will collect around 298.02 million by 2025, rising at the maximum CAGR of 11.5%. The instruments are further sub- segmented into newborn disorder screening, newborn hearing screening, and pulse oximeter.

Technology:  Tandem mass spectrometry market is likely to dominate market with 27.2% shares and is estimated to reach 122.47 million by 2025. It is growing at the highest CAGR of 11.9% in the forecast period.

Disease Type: Critical congenital heart diseases market will dominate with 65.1% shares and will consume around 286.45 million by 2025. It is growing at the highest CAGR of 11.5% in the assessment period.

End-user: Hospitals market is expected to dominate market with 71.4% shares and is estimated to reach 312.88 million by 2025, growing at the highest CAGR of 11.5%.

Table Of Content

Introduction
1.1. Objectives Of The Study
1.2. Market Definition
1.3. Overview Of Global Newborn Screening Market
1.4. Currency And Pricing
1.5. Limitation
1.6. Markets Covered

Market Segmentation
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For The Study
2.4. Currency And Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions

Market Overview
3.1. Drivers

3.1.1. Rising Prevalence Of Newborn Screening
3.1.2. Growth In Neonatal Diseases
3.1.3. Increased Government Initiatives
3.1.4. Technological Advancements In Screening

3.2. Restraints

Continue…

 
Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-newborn-screening-market

About Us

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
http://databridgemarketresearch.com

This release was published on openPR.